Exit for Andrew Alliance, the Swiss Robotic Medtech Company
13.01.2020
US company Waters Corporation (NYSE:WAT) announced today that it has entered into a definitive agreement to acquire Andrew Alliance, a Venture Kick and TOP 100 alumn.
 |
 |
Andrew Alliance is dedicated to advancing science by providing researchers connected and intuitive to use automation technology, including robots and cloud-native software for liquid handling. Andrew Alliance aims to dramatically improve the repeatability, performance, and speed of laboratory operations and chemistry workflows. This customer-centric approach, and Andrew+, the flagship robot, have won numerous accolades since 2013, transforming bench research in hundreds of pharmaceutical, diagnostic, and academic laboratories worldwide, by eliminating human errors, leaving time for better data analysis.
Andrew Alliance received support from Venture Kick in 2011 and was on the TOP 100 Swiss Startups list in 2012, 2013 and 2014. In June 2018, the company closed a Series C $14 million investment round.
“I’ve said before that without Venture Kick, Andrew Alliance would not have been created,” said founder Piero Zucchelli. “Seven years on we have turned that kick into a business that is relied on by top life sciences companies."
Commenting on the exit, the cofounder and CEO Piero Zucchelli states: “We are thrilled to join the Waters family. We have found the right partner to bring our vision of connected laboratories to life. Waters’ combination of instruments and chemistries will help us accelerate the delivery of our innovative software and hardware technologies to customers as mass spectrometry increasingly moves into the hands of more and more users.”
Andrew Alliance received support from Venture Kick in 2011 and was on the TOP 100 Swiss Startups list in 2012, 2013 and 2014. In June 2018, the company closed a Series C $14 million investment round.
“I’ve said before that without Venture Kick, Andrew Alliance would not have been created,” said founder Piero Zucchelli. “Seven years on we have turned that kick into a business that is relied on by top life sciences companies."
Commenting on the exit, the cofounder and CEO Piero Zucchelli states: “We are thrilled to join the Waters family. We have found the right partner to bring our vision of connected laboratories to life. Waters’ combination of instruments and chemistries will help us accelerate the delivery of our innovative software and hardware technologies to customers as mass spectrometry increasingly moves into the hands of more and more users.”